The placebo and why we need it
People often feel better after taking *any* pill — even a sugar one — because of expectation, attention from doctors, and the natural tendency of many illnesses to ease over time. This is the placebo effect, and it is real and sometimes large. A placebo is a dummy treatment made to look identical to the real drug. By giving one group the drug and another the placebo, we can measure the drug's *extra* benefit on top of all that hope and natural recovery.
Randomization and blinding
Two more tools keep the comparison honest. Randomization assigns each participant to drug or placebo by chance, so the two groups are similar in age, severity, and luck — any leftover difference is more likely due to the drug. Blinding hides who got what.
- Single-blind — the participant doesn't know which they received, so expectation can't bias how they feel or report.
- [[double-blind-study|Double-blind]] — neither the participant nor the treating staff knows, so doctors can't unconsciously nudge results or judge outcomes differently between groups.
- The code linking each person to their treatment is locked away and only opened after the data are analysed.
Reading the result honestly
A well-run double-blind randomized Phase III trial is the backbone of evidence-based medicine. But 'statistically significant' is not the same as 'big enough to matter'. One plain way to express benefit is the number needed to treat (NNT): how many people must take the drug for one extra person to benefit. A low NNT (say, 5) is a strong treatment; a high NNT (say, 100) is weak — and must always be weighed against the side effects those 100 people also risk.